Meddenovo - Drug Discovery company was founded by academics who have been conducting scientific research on drug design and modeling of biomolecular systems for more than 10 years.
Our main goal in the establishment of Meddenovo is to bring high levels of computational chemistry and simulation techniques together with research groups and companies for joint drug discovery.
The diverse and complex diseases and the pandemic process that deeply shook the whole world show that innovative transformations in medicine is a constant need. In order to meet this need effectively, more high technology inputs are needed in drug discovery research. As Meddenovo, we are proud to be a one of the companies to provide high-tech solutions in drug design with our software and our team of experienced scientists
We model the target inhibition ability of your molecular sets that have the potential to work in any therapeutic area by using computational chemisRead More
At Meddenovo, we carry out studies where we reveal the potential of millions of drug candidate molecules, both with the software that we have develRead More
We create a peptide database specific to your project for the target macromolecule that you have determined in your research. We test the peptidesRead More
We reveal yield enhancement methods by modeling enzymatic or organic reactions. We also evaluate toxicity problems or possible degradation routes.<Read More
In biomolecular drug and enzyme design studies, we calculate the protein's response under changing conditions by conducting molecular dynamicsRead More
We calculate the IR, UV-vis, NMR spectra and optical properties of your drug candidates or any other molecules that you plan to develop. We help exRead More
One of the fundamental stages of scientific research is to establish a hypothesis. The strength of the hypothesis and its support with interdisciplinary studies increase the success of scientific research projects. All national and international funds provided to research and development activities support projects with a high chance of success.
At Meddenovo, we verify the hypotheses of your pharmaceutical, chemical or biological-based projects using simulations. Thanks to these simulations, we increase the chance of your project, whose hypothesis has been proven theoretically, to receive support from highly competitive funds. On the other hand, we strengthen your risk management by revealing possible unforeseen problems in project design.
Some of the projects that the Meddenovo team has contributed to in the hypothesis validation stages in recent years:
TÜBİTAK 1501, 2021, Peptiteam Chemistry Inc., Eczacıbaşı-Monrol
IRAD Funds, Ashwin-Ushas Corp.